High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma

作者: Simi Santala , Anne Talvensaari-Mattila , Ylermi Soini , Maria Honkavuori-Toivola , Markku Santala

DOI: 10.1007/S13277-014-1703-9

关键词:

摘要: Cyclins are a group of proteins that act as activators to cyclin-dependent kinases and required for normal cell cycle transitions. Cyclin A is involved in the transitions between G1 S G2 M. Its deregulation has been linked number neoplasms, including endometrial cancer. The prognostic significance cyclin expression seems be cancer-specific, current knowledge on its impact survival cancer limited. This study aimed investigate effect cancer-specific correlation with conventional factors endometrioid adenocarcinoma. Biopsies obtained from 211 patients were immunohistochemically stained differences analyzed at Oulu University Hospital. Patients divided into two groups utilizing ROC curve. Further analyses carried out these groups. In this study, we show correlates tumor grade FIGO stage. We also an independent factor Whether plays role tumorigenesis or merely marker increased proliferation requires further studies.

参考文章(18)
Amber Yasmeen, Wolfgang E Berdel, Hubert Serve, Carsten Müller-Tidow, E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Review of Molecular Diagnostics. ,vol. 3, pp. 617- 633 ,(2003) , 10.1586/14737159.3.5.617
W.T. Creasman, F. Odicino, P. Maisonneuve, U. Beller, J.L. Benedet, A.P.M. Heintz, H.Y.S. Ngan, S. Pecorelli, Carcinoma of the Corpus Uteri International Journal of Gynecology & Obstetrics. ,vol. 83, pp. 79- 118 ,(2003) , 10.1016/S0020-7292(03)90116-0
Roberto Angioli, Francesco Plotti, Stella Capriglione, Roberto Montera, Patrizio Damiani, Roberto Ricciardi, Alessia Aloisi, Daniela Luvero, Ester Valentina Cafà, Nella Dugo, Michela Angelucci, Pierluigi Benedetti-Panici, The role of novel biomarker HE4 in endometrial cancer: a case control prospective study Tumor Biology. ,vol. 34, pp. 571- 576 ,(2013) , 10.1007/S13277-012-0583-0
F. KAYASELCUK, S. ERKANLI, F. BOLAT, G. SEYDAOGLU, E. KUSCU, B. DEMIRHAN, Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters. International Journal of Gynecological Cancer. ,vol. 16, pp. 402- 408 ,(2006) , 10.1111/J.1525-1438.2006.00407.X
Patricia E. Ellis, Sadaf Ghaem-Maghami, Molecular characteristics and risk factors in endometrial cancer: what are the treatment and preventative strategies? International Journal of Gynecological Cancer. ,vol. 20, pp. 1207- 1216 ,(2010) , 10.1111/IGC.0B013E3181F1A400
Józefa Węsierska-Gądek, Margarita Maurer, Nora Zulehner, Oxana Komina, Whether to target single or multiple CDKs for therapy? That is the question Journal of Cellular Physiology. ,vol. 226, pp. 341- 349 ,(2011) , 10.1002/JCP.22426
William Creasman, Revised FIGO staging for carcinoma of the endometrium International Journal of Gynecology & Obstetrics. ,vol. 105, pp. 109- 109 ,(2009) , 10.1016/J.IJGO.2009.02.010
Jun Watanabe, Yukari Nishimura, Shinpei Tsunoda, Miwa Kawaguchi, Isao Okayasu, Hiroyuki Kuramoto, Liquid-based preparation for endometrial cytology-Usefulness for predicting the prognosis of endometrial carcinoma preoperatively Cancer Cytopathology. ,vol. 117, pp. 254- 263 ,(2009) , 10.1002/CNCY.20035
Maria Honkavuori-Toivola, Anne Talvensaari-Mattila, Ylermi Soini, Taina Turpeenniemi-Hujanen, Markku Santala, Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma. Tumor Biology. ,vol. 33, pp. 935- 941 ,(2012) , 10.1007/S13277-012-0321-7